EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

COVID‐19 Prophylactic Effect of Bromhexine Hydrochloride

Vanyo Mitev iD, Tsanko Mondeshki iD, Ani Miteva iD, Konstantin Tachkov iD, Violeta Dimitrova iD

Immunity, Inflammation and Disease · 2026-04 · 14 (4)

DOI: 10.1002/iid3.70438 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 20.04.2026. Verfasst von Vanyo Mitev und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Innovative Medical Science, Medical University-Sofia, Sofia, Bulgaria. Hauptthemen laut MEDLINE: Bromhexine, COVID-19, Expectorants. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bulgarian National Science, Bulgarian National Plan for Recovery and Resilience.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Despite extensive efforts to identify effective treatments for COVID‐19, preventive strategies remain essential. Bromhexine hydrochloride (BRH), an over‐the‐counter mucolytic with potential TMPRSS2 inhibition, may reduce viral entry and thus serve as a prophylactic agent.

Methods

A retrospective questionnaire‐based study included 125 individuals reporting prophylactic BRH use. Demographic and clinical data were collected. COVID‐19 infection rates before and after BRH use were compared. Subgroup analyses were performed by vaccination status, prior infection, and duration of prophylaxis.

Results

Participants had a mean age of 56.5 years and a mean BMI of 25.6; 20% were vaccinated. Prior to BRH use, 62.4% reported COVID‐19 infection, compared to 11.2% after prophylaxis ( p < 0.0001). Significant reductions were observed in both vaccinated (48.1% vs. 3.7%, p = 0.002) and unvaccinated individuals (66.3% vs. 13.3%, p < 0.0001). Prior infection did not significantly influence outcomes ( p = 0.9248). Longer BRH use was associated with lower reinfection rates, decreasing from 33.3% (≤ 10 days) to 2.6% (≥ 30 days) ( p = 0.003).

Conclusions

BRH prophylaxis was associated with reduced reported COVID‐19 infection rates, independent of vaccination or prior infection, with greater benefit observed with longer use. Prospective controlled studies are required to confirm these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BromhexineCOVID-19ExpectorantsHumansRetrospective StudiesFemaleMiddle AgedMaleSARS-CoV-2AgedSurveys and QuestionnairesPandemics

Stichwörter der Autor:innen

BromhexineCOVID‐19ProphylacticsTMPRSS2

Substanzen

BromhexineExpectorants

Autor:innen und Institutionen

  • Research Institute of Innovative Medical Science, Medical University-Sofia, Sofia, Bulgaria.
  • Department of Medical Chemistry and Biochemistry, Medical Faculty, Medical University-Sofia, Sofia, Bulgaria.
  • Department of Propaedeutics of Internal Diseases, University Hospital Alexandrovska, Medical University-Sofia, Sofia, Bulgaria.
  • Department of Bioethics, Faculty of Public Health, Medical University-Sofia, Sofia, Bulgaria.
  • Department of Social Pharmacy and Pharmaco-economics, Faculty of Pharmacy, Medical University-Sofia, Sofia, Bulgaria.

ORCID-Profile: Vanyo Mitev, Tsanko Mondeshki, Ani Miteva, Konstantin Tachkov, Violeta Dimitrova

Förderung

  • Bulgarian National Science
  • Bulgarian National Plan for Recovery and Resilience

Zitieren

APA

Mitev, V., Mondeshki, T., Miteva, A., Tachkov, K., & Dimitrova, V. (2026). COVID‐19 Prophylactic Effect of Bromhexine Hydrochloride. Immunity, Inflammation and Disease, 14(4). https://doi.org/10.1002/iid3.70438

Vancouver

Mitev V, Mondeshki T, Miteva A, Tachkov K, Dimitrova V. COVID‐19 Prophylactic Effect of Bromhexine Hydrochloride. Immunity, Inflammation and Disease. 2026;14(4). doi:10.1002/iid3.70438

BibTeX
@article{Mitev2026,
  author = {Mitev, Vanyo and Mondeshki, Tsanko and Miteva, Ani and Tachkov, Konstantin and Dimitrova, Violeta},
  title = {COVID‐19 Prophylactic Effect of Bromhexine Hydrochloride},
  journal = {Immunity, Inflammation and Disease},
  year = {2026},
  volume = {14},
  number = {4},
  doi = {10.1002/iid3.70438}
}
Kostenlos starten →